Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CHRS compared with KLRS: revenue, margins and what each company keeps, and the suppliers and customers both name
CHRS
Coherus Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
KLRS
Kalaris Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CHRS
Coherus Oncology, Inc.
vs
KLRS
Kalaris Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CHRS, solid
KLRS, dashed
CHRS
Coherus Oncology, Inc.
Change
0.87
· pre 0.85
Mkt cap
$128.3M
Revenue
$14M
Q2 FY26
Revenue
$42M
FY25
KLRS
Kalaris Therapeutics, Inc.
Change
2.00
· pre 2.04
· delayed
Pre-market
Sep 2 '83
Mkt cap
$48.3M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Sep 2 '83
CHRS
Coherus Oncology, Inc.
vs
KLRS
Kalaris Therapeutics, Inc.
0.87
pre 0.85
Price
2.00
pre 2.04
delayed
$128.3M
Mkt cap
$48.3M
Q2 FY26
$14M
Revenue
—
FY25
$42M
Revenue
—
Change
Change
CHRS
0.87
vs
KLRS
2.00
Pre-market
Sep 2 '83